Lb Pharmaceuticals (LBRX) Change in Cash (2024 - 2026)

Lb Pharmaceuticals' Change in Cash history runs 3 years deep, the most recent figure standing at $70.5 million for Q1 2026.

• On a quarterly basis, Change in Cash rose 2339.8% year-over-year to $70.5 million in Q1 2026; TTM through Mar 2026 was $55.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $227.5 million, up 2577.03% from the prior year.
• Change in Cash advanced to $70.5 million in Q1 2026 per LBRX's latest filing, from -$19.3 million in the prior quarter.
• Across five years, Change in Cash topped out at $70.5 million in Q1 2026 and bottomed at -$19.3 million in Q4 2025.
• The 3-year median for Change in Cash is $2.4 million (2024), against an average of $14.0 million.
• Across the five-year window, Change in Cash sank 345.31% in 2025 and jumped 2339.8% in 2026, its largest moves.
• Year by year, Change in Cash stood at $7.9 million in 2024, then slumped by 345.31% to -$19.3 million in 2025, then surged by 465.09% to $70.5 million in 2026.
• Per Business Quant, the three latest LBRX Change in Cash figures stand at $70.5 million (Q1 2026), -$19.3 million (Q4 2025), and -$3.1 million (Q1 2025).